Tongue hyperpigmentation resulting from peginterferon alfa-2a and ribavirin treatment in a Caucasian patient with chronic hepatitis C

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 11, 2008, Pages 1389-1391

  Fernandez A ^a   Vazquez S ^a   Rodriguez Gonzalez L ^a  

^a HOSPITAL POVISA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERPIGMENTATION; LETTER; NEUTROPENIA; NEUTROPHIL COUNT; PRIORITY JOURNAL; TONGUE DISEASE; TREATMENT OUTCOME;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; PIGMENTATION DISORDERS; POLYETHYLENE GLYCOLS; RIBAVIRIN; TONGUE;

EID: 53749084958     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02653.x     Document Type: Letter

References (10)

1. Doutre MS. Hepatitis C virus-related skin diseases. Arch Dermatol 1999 135 : 1401 1403.
2. Dalekos GN, Christodoulou D, Kitis KG, Zervou EK, Hatzis J, Tsianos EV. A prospective evaluation of dermatological side-effects during alfa-interferon therapy for chronic viral hepatitis. Eur J Gastroenterol Hepatol 1998 10 : 933 939.
3. Sookoian S, Neglia V, Castano G, Frider B, Kien MC, Chohuela C. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999 135 : 1000 1001.
4. Gurguta C, Kauer C, Bergholz U, Formann E, Steindl-Munda P, Ferenci P. Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark skinned non-Caucasian patients with chronic hepatitis C. Am J Gastroenterol 2006 101 : 197 198.
5. Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol 2006 24 : 276 280.
6. Meyerson MA, Cohen PR, Hymes SR. Lingual hyperpigmentation associated with minocycline therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 79 : 180 184.
7. Merenich JA, Hannon RN, Gentry RH, Harrison SM. Azidothymidine-induced hyperpigmentatin mimicking primary adrenal insufficiency. Am J Med 1898 86 : 469 470.
8. Sood A, Midha V, Bansal M, Goyal A, Sharma M. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Indian J Gastroenterol 2006 25 : 324.
9. Willems M, Munte K, Vrolijk JM et al. Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol 2003 149 : 390 394.
10. Torres HA, Bull L, Arduino RC, Barnett BJ. Tongue hyperpigmentation in a Caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. Am J Gastroenterol 2007 102 : 1334 1335.